成人无码高潮av在线观看_欧洲极品少妇_夂久亚州精华国产精华华液_在线观看亚洲AV每日更新无码_亚洲国产精品无码久久一线_亚洲精品区午夜亚洲精品区

德國Diarect AG
在過去的20年里，DIARECT AG公司的專家致力于自身免疫分析的大量創(chuàng)新研究與開發(fā)：
1、基于重組甲狀腺過氧化物酶（TPO）的最早的甲狀腺過氧化物酶抗體的測試系統(tǒng)；
2、使用了幾種重組蛋白的最早的抗核抗體(ANA) /多肽抗體（ENA ）的分布和篩選分析；
3、最初的重組蛋白有增殖細(xì)胞核抗原（PCNA）, 蘇胺酰-tRNA合成酶（PL-7）, 丙胺酰-tRNA合成酶(PL-12) , 全長的 Mi-2蛋白, Ku (p70/p80) 等.

我們的承諾是進一步擴大產(chǎn)品系列，在未來的幾年來我們將繼續(xù)致力于開發(fā)新的自身抗原。

在免疫分析產(chǎn)品方面多年的經(jīng)驗告訴我們，產(chǎn)品的性能取決于高品質(zhì)的原料結(jié)合精益求精的研發(fā)。同等重要的還有關(guān)鍵原料質(zhì)量的可重復(fù)性，從而使產(chǎn)品后繼生產(chǎn)過程中的偏差降到最低。我們的專長是大批量生產(chǎn)以及保持各批次產(chǎn)品之間的一致性。

DIARECT AG的公司目標(biāo)是通過提供優(yōu)質(zhì)產(chǎn)品來改善分析的質(zhì)量水平從而增強分析性能。這個理念促使我們援助世界各地的病人和臨床免疫學(xué)家，與研究人員的科學(xué)合作，以及我們自己進行的學(xué)術(shù)參與，都促使著我們在這個方向上努力。

 Over the last two decades our experts have been involved in a number of innovative autoimmune assay developments:

First thyroid peroxidase antibody test system, based on recombinant TPO
First ANA/ENA profile and screening assay, utilizing several recombinant proteins
Introduction recombinant PCNA, PL-7, PL-12, full length Mi-2?, Ku (p70/p80) etc.
Since we are committed to further expand our product panel, we will strive to continue the development of new autoantigens in the years to come.

Manufacturing Experience
Years of experience in immunoassay production have taught us that test performance is the result of sophisticated assay development in combination with high-quality components. Equally important is the reproducible quality of these key components in order to minimize deviation in the subsequent manufacturing process. Large lot sizes as well as lot-to-lot consistency is our expertise.

Committed to Clinical Science
We at DIARECT AG aim to enhance assay performance by providing superior components for an improved assay quality level. This concept drives us to support patients and clinical immunologists worldwide. Scientific collaborations with researchers as well as our own ongoing academic involvement facilitate our efforts in this direction.